Published in J Mol Biol on February 02, 1996
A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules. Cell (2006) 7.07
Tuning genetic control through promoter engineering. Proc Natl Acad Sci U S A (2005) 4.07
A general chemical method to regulate protein stability in the mammalian central nervous system. Chem Biol (2010) 2.39
A general strategy for the evolution of bond-forming enzymes using yeast display. Proc Natl Acad Sci U S A (2011) 1.85
Architecture of a serine recombinase-DNA regulatory complex. Mol Cell (2008) 1.84
Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc Natl Acad Sci U S A (2003) 1.83
Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p. Mol Cell Biol (2001) 1.81
Latent evolutionary potentials under the neutral mutational drift of an enzyme. HFSP J (2007) 1.75
Hypermutagenic PCR involving all four transitions and a sizeable proportion of transversions. Nucleic Acids Res (1996) 1.67
A de novo protein binding pair by computational design and directed evolution. Mol Cell (2011) 1.65
Picomolar affinity fibronectin domains engineered utilizing loop length diversity, recursive mutagenesis, and loop shuffling. J Mol Biol (2008) 1.64
Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin. J Bacteriol (2001) 1.62
Genetic selection for protein solubility enabled by the folding quality control feature of the twin-arginine translocation pathway. Protein Sci (2006) 1.61
Chemical and biochemical strategies for the randomization of protein encoding DNA sequences: library construction methods for directed evolution. Nucleic Acids Res (2004) 1.46
Methods for the directed evolution of proteins. Nat Rev Genet (2015) 1.38
Tailoring in vitro evolution for protein affinity or stability. Proc Natl Acad Sci U S A (2001) 1.26
Mutations in the RNA polymerase III subunit Rpc11p that decrease RNA 3' cleavage activity increase 3'-terminal oligo(U) length and La-dependent tRNA processing. Mol Cell Biol (2005) 1.24
Physical and functional interactions between human mitochondrial single-stranded DNA-binding protein and tumour suppressor p53. Nucleic Acids Res (2008) 1.18
De novo generation of prion strains. Nat Rev Microbiol (2011) 1.17
Shuffled antibody libraries created by in vivo homologous recombination and yeast surface display. Nucleic Acids Res (2004) 1.16
Directed evolution can rapidly improve the activity of chimeric assembly-line enzymes. Proc Natl Acad Sci U S A (2007) 1.15
Selection of anthrax toxin protective antigen variants that discriminate between the cellular receptors TEM8 and CMG2 and achieve targeting of tumor cells. J Biol Chem (2007) 1.14
Feedback inhibition of chorismate mutase/prephenate dehydrogenase (TyrA) of Escherichia coli: generation and characterization of tyrosine-insensitive mutants. Appl Environ Microbiol (2005) 1.12
Improving dideoxynucleotide-triphosphate utilisation by the hyper-thermophilic DNA polymerase from the archaeon Pyrococcus furiosus. Nucleic Acids Res (2000) 1.11
Low-fidelity Pyrococcus furiosus DNA polymerase mutants useful in error-prone PCR. Nucleic Acids Res (2004) 1.07
Polymerase recognition of synthetic oligodeoxyribonucleotides incorporating degenerate pyrimidine and purine bases. Proc Natl Acad Sci U S A (1998) 1.07
Mutations enhance the aggregation propensity of the Alzheimer's A beta peptide. J Mol Biol (2008) 1.06
Directed evolution of a small-molecule-triggered intein with improved splicing properties in mammalian cells. Chem Biol (2011) 1.05
Unlocking hidden genomic sequence. Nucleic Acids Res (2004) 1.04
One-pot DNA construction for synthetic biology: the Modular Overlap-Directed Assembly with Linkers (MODAL) strategy. Nucleic Acids Res (2013) 1.03
Directed evolution of aryl carrier proteins in the enterobactin synthetase. Proc Natl Acad Sci U S A (2007) 1.01
Ambiguous base pairing of the purine analogue 1-(2-deoxy-beta-D-ribofuranosyl)-imidazole-4-carboxamide during PCR. Nucleic Acids Res (1996) 0.99
The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain. J Biol Chem (2007) 0.99
Regulatory mutations in Sin recombinase support a structure-based model of the synaptosome. Mol Microbiol (2009) 0.99
Destabilizing domains derived from the human estrogen receptor. J Am Chem Soc (2012) 0.98
Structural basis of regulation of von Willebrand factor binding to glycoprotein Ib. J Biol Chem (2014) 0.97
Sequence saturation mutagenesis (SeSaM): a novel method for directed evolution. Nucleic Acids Res (2004) 0.97
Design of pH sensitive binding proteins from the hyperthermophilic Sso7d scaffold. PLoS One (2012) 0.96
The molecular basis for the broad substrate specificity of human sulfotransferase 1A1. PLoS One (2011) 0.95
RNA polymerase III mutants in TFIIFα-like C37 that cause terminator readthrough with no decrease in transcription output. Nucleic Acids Res (2012) 0.95
Zinc finger recombinases with adaptable DNA sequence specificity. PLoS One (2011) 0.95
Histone H1- and other protein- and amino acid-hydroperoxides can give rise to free radicals which oxidize DNA. Biochem J (1999) 0.94
Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms. Nano Rev (2012) 0.93
The mechanism of mutation induction by a hydrogen bond ambivalent, bicyclic N4-oxy-2'-deoxycytidine in Escherichia coli. Nucleic Acids Res (1997) 0.93
A mixed mirror-image DNA/RNA aptamer inhibits glucagon and acutely improves glucose tolerance in models of type 1 and type 2 diabetes. J Biol Chem (2013) 0.90
Assessing directed evolution methods for the generation of biosynthetic enzymes with potential in drug biosynthesis. Future Med Chem (2011) 0.90
A cell-free microtiter plate screen for improved [FeFe] hydrogenases. PLoS One (2010) 0.89
High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands. Nucleic Acids Res (2002) 0.89
Isolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display library. BMC Biotechnol (2007) 0.87
Engineering hepatocyte growth factor fragments with high stability and activity as Met receptor agonists and antagonists. Proc Natl Acad Sci U S A (2011) 0.87
Bacteriophage-based genetic system for selection of nonsplicing inteins. Appl Environ Microbiol (2004) 0.84
Synthesis and RNA polymerase incorporation of the degenerate ribonucleotide analogue rPTP. Nucleic Acids Res (1998) 0.83
Antibody affinity maturation using yeast display with detergent-solubilized membrane proteins as antigen sources. Protein Eng Des Sel (2012) 0.82
Using droplet-based microfluidics to improve the catalytic properties of RNA under multiple-turnover conditions. RNA (2015) 0.82
Mistranslation drives the evolution of robustness in TEM-1 β-lactamase. Proc Natl Acad Sci U S A (2015) 0.82
Conformation-dependent recognition of HIV gp120 by designed ankyrin repeat proteins provides access to novel HIV entry inhibitors. J Virol (2013) 0.82
Deep sequencing analysis of mutations resulting from the incorporation of dNTP analogs. Nucleic Acids Res (2010) 0.81
In vitro selection using modified or unnatural nucleotides. Curr Protoc Nucleic Acid Chem (2002) 0.81
Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep (2013) 0.81
RNA mutagenesis yields highly diverse mRNA libraries for in vitro protein evolution. BMC Biotechnol (2007) 0.80
In vitro nanobody discovery for integral membrane protein targets. Sci Rep (2014) 0.80
A methods review on use of nonsense suppression to study 3' end formation and other aspects of tRNA biogenesis. Gene (2014) 0.80
Simulating pseudogene evolution in vitro: determining the true number of mutations in a lineage. Proc Natl Acad Sci U S A (2001) 0.79
Directed evolution of brain-derived neurotrophic factor for improved folding and expression in Saccharomyces cerevisiae. Appl Environ Microbiol (2014) 0.79
Genetically engineered virulent phage banks in the detection and control of emergent pathogenic bacteria. Biosecur Bioterror (2010) 0.79
In vivo elimination of parental clones in general and site-directed mutagenesis. J Immunol Methods (2014) 0.78
An improved protocol for sequencing of repetitive genomic regions and structural variations using mutagenesis and next generation sequencing. PLoS One (2012) 0.78
Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions. Protein Sci (2014) 0.77
An in vitro compartmentalization-based method for the selection of bond-forming enzymes from large libraries. Biotechnol Bioeng (2016) 0.76
In vitro selection using modified or unnatural nucleotides. Curr Protoc Nucleic Acid Chem (2014) 0.76
A Split-Ubiquitin Based Strategy Selecting for Protein Complex-Interfering Mutations. G3 (Bethesda) (2016) 0.75
Yeast Display-Based Antibody Affinity Maturation Using Detergent-Solubilized Cell Lysates. Methods Mol Biol (2015) 0.75
Active Center Control of Termination by RNA Polymerase III and tRNA Gene Transcription Levels In Vivo. PLoS Genet (2016) 0.75
An evolved Mxe GyrA intein for enhanced production of fusion proteins. ACS Chem Biol (2014) 0.75
Nucleotide binding interactions modulate dNTP selectivity and facilitate 8-oxo-dGTP incorporation by DNA polymerase lambda. Nucleic Acids Res (2015) 0.75
Engineered ligand-based VEGFR antagonists with increased receptor binding affinity more effectively inhibit angiogenesis. Bioeng Transl Med (2017) 0.75
Amino acid residues important for folding of thioredoxin are revealed only by study of the physiologically relevant reduced form of the protein. Biochemistry (2010) 0.75
Streamlining the Pipeline for Generation of Recombinant Affinity Reagents by Integrating the Affinity Maturation Step. Int J Mol Sci (2015) 0.75
Integrated mimicry of B cell antibody mutagenesis using yeast homologous recombination. Mol Biotechnol (2011) 0.75
Anthrax Toxin Protective Antigen Variants That Selectively Utilize either the CMG2 or TEM8 Receptors for Cellular Uptake and Tumor Targeting. J Biol Chem (2016) 0.75
New Recombinant Mycobacterium bovis BCG Expression Vectors: Improving Genetic Control over Mycobacterial Promoters. Appl Environ Microbiol (2016) 0.75
Synthetic nucleotides as probes of DNA polymerase specificity. J Nucleic Acids (2012) 0.75
Biomolecular engineering for nanobio/bionanotechnology. Nano Converg (2017) 0.75
Targeting insulin receptor in breast cancer using small engineered protein scaffolds. Mol Cancer Ther (2017) 0.75
Some aspects of E. coli promoter evolution observed in a molecular evolution experiment. J Mol Evol (2006) 0.75
New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature (1967) 6.96
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (1987) 6.26
Scatter factor/hepatocyte growth factor is essential for liver development. Nature (1995) 5.91
An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet (1997) 5.65
Structural-functional relationships in diabetic nephropathy. J Clin Invest (1984) 4.78
Base-specific reactions useful for DNA sequencing: methylene blue--sensitized photooxidation of guanine and osmium tetraoxide modification of thymine. Nucleic Acids Res (1978) 4.20
The path to full accreditation: CMCC and its governors, 1945-86. Chiropr Hist (1987) 3.80
"Penbritin"-A New Broad-spectrum Antibiotic. Br Med J (1961) 3.76
Primary structures of six antimicrobial peptides of rabbit peritoneal neutrophils. J Biol Chem (1985) 3.58
Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19
Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol (1994) 3.06
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol (1998) 3.05
Cloning restriction fragments that promote expression of a gene in Bacillus subtilis. J Bacteriol (1981) 3.01
Primary structures of MCP-1 and MCP-2, natural peptide antibiotics of rabbit lung macrophages. J Biol Chem (1983) 3.00
Drug-induced aplastic anemia. Semin Hematol (1973) 2.81
The role of antibody in host defense against the agent of mouse pneumonitis. J Infect Dis (1982) 2.78
5-Nitroindole as an universal base analogue. Nucleic Acids Res (1994) 2.78
Modulation of Ca(2+) entry by polypeptides of the inositol 1,4, 5-trisphosphate receptor (IP3R) that bind transient receptor potential (TRP): evidence for roles of TRP and IP3R in store depletion-activated Ca(2+) entry. Proc Natl Acad Sci U S A (1999) 2.52
A high-density integrated genetic linkage and radiation hybrid map of the laboratory rat. Genome Res (1999) 2.49
Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat Med (1995) 2.43
The structure of triphosphoinositide from beef brain. Biochim Biophys Acta (1966) 2.41
Treatment of murine cryptococcosis with liposome-associated amphotericin B. J Infect Dis (1982) 2.36
Sequence analysis of mutations that affect the synthesis, assembly and enzymatic activity of the unc-54 myosin heavy chain of Caenorhabditis elegans. J Mol Biol (1985) 2.29
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones. Infect Immun (1994) 2.29
Cellular immunity to the mouse pneumonitis agent. J Infect Dis (1984) 2.28
Effect of gamma interferon on resolution of murine chlamydial genital infection. Infect Immun (1992) 2.24
Nucleotide sequence of a Bacillus pumilus gene specifying chloramphenicol acetyltransferase. Gene (1983) 2.17
Adverse health effects of PM10 particles: involvement of iron in generation of hydroxyl radical. Occup Environ Med (1996) 2.12
A genetic linkage map of the laboratory rat, Rattus norvegicus. Nat Genet (1995) 2.10
Structural repertoire of the human VH segments. J Mol Biol (1992) 2.06
The effect of high-frequency random mutagenesis on in vitro protein evolution: a study on TEM-1 beta-lactamase. J Mol Biol (1999) 2.00
Effect of tobacco and alcohol consumption on the Langerhans cell population of human lingual epithelium determined using a monoclonal antibody against HLADR. J Oral Pathol Med (1991) 2.00
The formation of bacterial flagella. 3. Characterization of the subunits of the flagella of Bacillus subtilis and Spirillum serpens. J Mol Biol (1967) 1.99
Original and artificial antibodies. Nature (1992) 1.97
Chloramphenicol-inducible gene expression in Bacillus subtilis. Gene (1983) 1.96
Successful bone-marrow transplantation for infantile malignant osteopetrosis. N Engl J Med (1980) 1.95
Genetic control of murine resistance to Toxoplasma gondii. Infect Immun (1978) 1.91
A new linkage for solid phase synthesis of oligodeoxyribonucleotides. Nucleic Acids Res (1985) 1.90
Hyperinsulinaemic hypoglycaemia in small for dates babies. Arch Dis Child (1990) 1.86
Strain-dependent differences in murine susceptibility to toxoplasma. Infect Immun (1976) 1.85
Spectroscopic properties of C-phycocyanin and of its alpha and beta subunits. J Biol Chem (1973) 1.84
Pulmonary infection in the compromised host: part I. Am Rev Respir Dis (1976) 1.82
Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros. J Cell Biol (1995) 1.79
Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am Rev Respir Dis (1982) 1.77
Hepatocytes and scatter factor. Nature (1990) 1.77
Studies of the rate of regression of the glomerular lesions in diabetic rats treated with pancreatic islet transplantation. Diabetes (1975) 1.74
Genome scan of schizophrenia. Am J Psychiatry (1998) 1.74
Replication-competent picornaviruses with complete genomic RNA 3' noncoding region deletions. J Virol (1997) 1.73
Biodiversity at the molecular level: the domains, kingdoms and phyla of life. Philos Trans R Soc Lond B Biol Sci (1994) 1.67
Regulatory regions that control expression of two chloramphenicol-inducible cat genes cloned in Bacillus subtilis. J Bacteriol (1984) 1.66
Selective reaction of methoxyamine with cytosine bases in tyrosine transfer ribonucleic acid. J Mol Biol (1971) 1.61
Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis (1987) 1.59
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis (1981) 1.58
Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. J Biol Chem (1999) 1.58
Role of CD8 T cells in primary Chlamydia infection. Infect Immun (1995) 1.56
Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun (1988) 1.56
Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytomedicine (1996) 1.56
Streptococcal infection in piglets: the palatine tonsils as portals of entry for Streptococcus suis. Res Vet Sci (1973) 1.55
IADR Global Oral Health Inequalities Research Agenda (IADR-GOHIRA(R)): a call to action. J Dent Res (2013) 1.53
Regulation of cell movement: the motogenic cytokines. Biochim Biophys Acta (1991) 1.53
Free radical activity of PM10: iron-mediated generation of hydroxyl radicals. Environ Health Perspect (1997) 1.53
Ulcerlike lesions of the aorta: imaging features and natural history. Radiology (2001) 1.52
The effects of Goldblatt hypertension on development of the glomerular lesions of diabetes mellitus in the rat. Diabetes (1978) 1.52
3-Nitropyrrole and 5-nitroindole as universal bases in primers for DNA sequencing and PCR. Nucleic Acids Res (1995) 1.51
Surgical delay for acute type A dissection with malperfusion. Ann Thorac Surg (1997) 1.50
Requirements for assembly of poliovirus replication complexes and negative-strand RNA synthesis. J Virol (2001) 1.50
Synthesis and duplex stability of oligonucleotides containing cytosine-thymine analogues. Nucleic Acids Res (1989) 1.50
Biliproteins of cyanobacteria and Rhodophyta: Homologous family of photosynthetic accessory pigments. Proc Natl Acad Sci U S A (1976) 1.49
Expression of Escherichia coli trp genes and the mouse dihydrofolate reductase gene cloned in Bacillus subtilis. Gene (1981) 1.49
Physico-chemical and immunological properties of allophycocyanins. Arch Microbiol (1977) 1.49
Antibody in host defense against mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1984) 1.47
The kidney in diabetes. Am J Med (1981) 1.47
Tumor necrosis factor-alpha plays a role in host defense against Histoplasma capsulatum. J Infect Dis (1990) 1.46
In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J Pathol (1996) 1.43
2'-Fluoro- and 2'-amino-2'-deoxynucleoside 5'-triphosphates as substrates for T7 RNA polymerase. Biochemistry (1992) 1.41
Breath-hold gadolinium-enhanced MR angiography of the abdominal aorta and its major branches. Radiology (1995) 1.41
Portal hypertension in vinyl-chloride production workers. Lancet (1976) 1.40
Androgen receptor gene mutations identified by SSCP in fourteen subjects with androgen insensitivity syndrome. Hum Mol Genet (1992) 1.40
Low infusion rate digital subtraction angiography to predict regional perfusion in hepatic arterial chemotherapy. Cardiovasc Intervent Radiol (1990) 1.39
A common protein binds to two silencers 5' to the human beta-globin gene. Nucleic Acids Res (1989) 1.36
Mutation and selection during the secondary response to 2-phenyloxazolone. Proc Natl Acad Sci U S A (1991) 1.35
Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest (1978) 1.35
The multinucleate cells in giant cell granulomas of the jaw are osteoclasts. Cancer (1988) 1.34
Role of natural killer cells in infection with the mouse pneumonitis agent (murine Chlamydia trachomatis). Infect Immun (1987) 1.33
The tautomeric state of N(4)-hydroxy- and of N(4)-amino-cytosine derivatives. J Chem Soc Perkin 1 (1968) 1.33
Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis (1981) 1.33
Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6. Infect Immun (1992) 1.33
Histoplasma capsulatum infection in nude mice. Infect Immun (1978) 1.31
Human glomerular smooth muscle (mesangial) cells in culture. Lab Invest (1976) 1.31
Characterization of the subunits of the flagella of Proteus vulgaris. J Biol Chem (1969) 1.31
In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance. Diabetes (1984) 1.30
Involvement of superoxide dismutase and pyruvate:ferredoxin oxidoreductase in mechanisms of metronidazole resistance in Entamoeba histolytica. J Antimicrob Chemother (1997) 1.30
Molecular evolution and domain structure of plasminogen-related growth factors (HGF/SF and HGF1/MSP). Protein Sci (1994) 1.29
Spiral CT of renal artery stenosis: comparison of three-dimensional rendering techniques. Radiology (1994) 1.29
Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity. Rev Infect Dis (1986) 1.29
Short-term study of the effect of phenacetin, phenazone and amidopyrine on the rat kidney. Br J Pharmacol Chemother (1968) 1.29
Epithelial scatter factor and development of the chick embryonic axis. Development (1990) 1.28
Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor. EMBO J (2001) 1.28
Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes (1978) 1.28
EMG frequency content changes with increasing force and during fatigue in the quadriceps femoris muscle of men and women. J Electromyogr Kinesiol (2003) 1.27